Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: MarketLine | PRODUCT CODE: 1125536

Cover Image

PUBLISHER: MarketLine | PRODUCT CODE: 1125536

Generics Market Summary, Competitive Analysis and Forecast, 2017-2026 (Global Almanac)

PUBLISHED:
PAGES: 498 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 2995
PDF (Site License)
USD 5990
PDF (Enterprise License)
USD 8985

Add to Cart

Summary

Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.

The market value is evaluated at ex-factory prices.

Market volume is quantified here as the percentage of the total ethical pharmaceutical market volume in a country or region which is accounted for by generic drugs. It is therefore a generics penetration rate measure, not an absolute measure of market volume.

Regional volumes are calculated as weighted averages of countries which make up the region in question where volume data exists.

Note that any volumes of "1" (one) or 100% are due to rounding as MarketLine does not believe that generics will ever fully represent 100% of the medicinal market in any country or region.

All market data and forecasts are represented in nominal terms (i.e., without adjustment for inflation) and all currency conversions used in the creation of this report have been calculated using constant 2021 annual average exchange rates.

The global generics market had total revenues of $321.4 billion in 2021, representing a compound annual growth rate (CAGR) of 4.7% between 2016 and 2021.

Market consumption volume increased with a CAGR of 1.9% between 2016 and 2021, to reach a total of 47.0 % in 2021.

Over the past five years, the global generics market recorded growth of 5.2%. Growth has primarily been driven by demographic trends.

Scope

  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the global generics market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global generics market
  • Leading company profiles reveal details of key generics market players' global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the global generics market with five year forecasts by both value and volume

Reasons to Buy

  • What was the size of the global generics market by value in 2021?
  • What will be the size of the global generics market in 2026?
  • What factors are affecting the strength of competition in the global generics market?
  • How has the market performed over the last five years?
  • How large is the global generics market in relation to its regional counterparts?
Product Code: MLIG220030-01

Table of Contents

1 EXECUTIVE SUMMARY

  • 1.1. Market value
  • 1.2. Market value forecast
  • 1.3. Market volume
  • 1.4. Market volume forecast
  • 1.5. Geography segmentation
  • 1.6. Competitive Landscape

2 Introduction

  • 2.1. What is this report about?
  • 2.2. Who is the target reader?
  • 2.3. How to use this report
  • 2.4. Definitions

3 Global Generics

  • 3.1. Market Overview
  • 3.2. Market Data
  • 3.3. Market Segmentation
  • 3.4. Market outlook
  • 3.5. Five forces analysis

4 Macroeconomic Indicators

  • 4.1. Country data

5 Generics in Asia-Pacific

  • 5.1. Market Overview
  • 5.2. Market Data
  • 5.3. Market Segmentation
  • 5.4. Market outlook
  • 5.5. Five forces analysis

6 Generics in Europe

  • 6.1. Market Overview
  • 6.2. Market Data
  • 6.3. Market Segmentation
  • 6.4. Market outlook
  • 6.5. Five forces analysis

7 Macroeconomic Indicators

  • 7.1. Country data

8 Generics in France

  • 8.1. Market Overview
  • 8.2. Market Data
  • 8.3. Market Segmentation
  • 8.4. Market outlook
  • 8.5. Five forces analysis

9 Macroeconomic Indicators

  • 9.1. Country data

10 Generics in Germany

  • 10.1. Market Overview
  • 10.2. Market Data
  • 10.3. Market Segmentation
  • 10.4. Market outlook
  • 10.5. Five forces analysis

11 Macroeconomic Indicators

  • 11.1. Country data

12 Generics in Australia

  • 12.1. Market Overview
  • 12.2. Market Data
  • 12.3. Market Segmentation
  • 12.4. Market outlook
  • 12.5. Five forces analysis

13 Macroeconomic Indicators

  • 13.1. Country data

14 Generics in Brazil

  • 14.1. Market Overview
  • 14.2. Market Data
  • 14.3. Market Segmentation
  • 14.4. Market outlook
  • 14.5. Five forces analysis

15 Macroeconomic Indicators

  • 15.1. Country data

16 Generics in Canada

  • 16.1. Market Overview
  • 16.2. Market Data
  • 16.3. Market Segmentation
  • 16.4. Market outlook
  • 16.5. Five forces analysis

17 Macroeconomic Indicators

  • 17.1. Country data

18 Generics in China

  • 18.1. Market Overview
  • 18.2. Market Data
  • 18.3. Market Segmentation
  • 18.4. Market outlook
  • 18.5. Five forces analysis

19 Macroeconomic Indicators

  • 19.1. Country data

20 Generics in India

  • 20.1. Market Overview
  • 20.2. Market Data
  • 20.3. Market Segmentation
  • 20.4. Market outlook
  • 20.5. Five forces analysis

21 Macroeconomic Indicators

  • 21.1. Country data

22 Generics in Indonesia

  • 22.1. Market Overview
  • 22.2. Market Data
  • 22.3. Market Segmentation
  • 22.4. Market outlook
  • 22.5. Five forces analysis

23 Macroeconomic Indicators

  • 23.1. Country data

24 Generics in Italy

  • 24.1. Market Overview
  • 24.2. Market Data
  • 24.3. Market Segmentation
  • 24.4. Market outlook
  • 24.5. Five forces analysis

25 Macroeconomic Indicators

  • 25.1. Country data

26 Generics in Japan

  • 26.1. Market Overview
  • 26.2. Market Data
  • 26.3. Market Segmentation
  • 26.4. Market outlook
  • 26.5. Five forces analysis

27 Macroeconomic Indicators

  • 27.1. Country data

28 Generics in Mexico

  • 28.1. Market Overview
  • 28.2. Market Data
  • 28.3. Market Segmentation
  • 28.4. Market outlook
  • 28.5. Five forces analysis

29 Macroeconomic Indicators

  • 29.1. Country data

30 Generics in The Netherlands

  • 30.1. Market Overview
  • 30.2. Market Data
  • 30.3. Market Segmentation
  • 30.4. Market outlook
  • 30.5. Five forces analysis

31 Macroeconomic Indicators

  • 31.1. Country data

32 Generics in North America

  • 32.1. Market Overview
  • 32.2. Market Data
  • 32.3. Market Segmentation
  • 32.4. Market outlook
  • 32.5. Five forces analysis

33 Generics in Russia

  • 33.1. Market Overview
  • 33.2. Market Data
  • 33.3. Market Segmentation
  • 33.4. Market outlook
  • 33.5. Five forces analysis

34 Macroeconomic Indicators

  • 34.1. Country data

35 Generics in Scandinavia

  • 35.1. Market Overview
  • 35.2. Market Data
  • 35.3. Market Segmentation
  • 35.4. Market outlook
  • 35.5. Five forces analysis

36 Generics in Singapore

  • 36.1. Market Overview
  • 36.2. Market Data
  • 36.3. Market Segmentation
  • 36.4. Market outlook
  • 36.5. Five forces analysis

37 Macroeconomic Indicators

  • 37.1. Country data

38 Generics in South Africa

  • 38.1. Market Overview
  • 38.2. Market Data
  • 38.3. Market Segmentation
  • 38.4. Market outlook
  • 38.5. Five forces analysis

39 Macroeconomic Indicators

  • 39.1. Country data

40 Generics in South Korea

  • 40.1. Market Overview
  • 40.2. Market Data
  • 40.3. Market Segmentation
  • 40.4. Market outlook
  • 40.5. Five forces analysis

41 Macroeconomic Indicators

  • 41.1. Country data

42 Generics in Spain

  • 42.1. Market Overview
  • 42.2. Market Data
  • 42.3. Market Segmentation
  • 42.4. Market outlook
  • 42.5. Five forces analysis

43 Macroeconomic Indicators

  • 43.1. Country data

44 Generics in Turkey

  • 44.1. Market Overview
  • 44.2. Market Data
  • 44.3. Market Segmentation
  • 44.4. Market outlook
  • 44.5. Five forces analysis

45 Macroeconomic Indicators

  • 45.1. Country data

46 Generics in The United Kingdom

  • 46.1. Market Overview
  • 46.2. Market Data
  • 46.3. Market Segmentation
  • 46.4. Market outlook
  • 46.5. Five forces analysis

47 Macroeconomic Indicators

  • 47.1. Country data

48 Generics in The United States

  • 48.1. Market Overview
  • 48.2. Market Data
  • 48.3. Market Segmentation
  • 48.4. Market outlook
  • 48.5. Five forces analysis

49 Macroeconomic Indicators

  • 49.1. Country data

50 Company Profiles

51 Appendix

  • 51.1. Methodology
  • 51.2. About MarketLine
Product Code: MLIG220030-01

List of Tables

  • Table 1: Global generics market value: $ billion, 2016-21
  • Table 2: Global generics market volume: %, 2016-21
  • Table 3: Global generics market geography segmentation: $ billion, 2021
  • Table 4: Global generics market value forecast: $ billion, 2021-26
  • Table 5: Global generics market volume forecast: %, 2021-26
  • Table 6: Global size of population (million), 2017-21
  • Table 7: Global gdp (constant 2005 prices, $ billion), 2017-21
  • Table 8: Global gdp (current prices, $ billion), 2017-21
  • Table 9: Global inflation, 2017-21
  • Table 10: Global consumer price index (absolute), 2017-21
  • Table 11: Global exchange rate, 2017-21
  • Table 12: Asia-Pacific generics market value: $ billion, 2016-21
  • Table 13: Asia-Pacific generics market volume: %, 2016-21
  • Table 14: Asia-Pacific generics market geography segmentation: $ billion, 2021
  • Table 15: Asia-Pacific generics market value forecast: $ billion, 2021-26
  • Table 16: Asia-Pacific generics market volume forecast: %, 2021-26
  • Table 17: Europe generics market value: $ billion, 2016-21
  • Table 18: Europe generics market volume: %, 2016-21
  • Table 19: Europe generics market geography segmentation: $ billion, 2021
  • Table 20: Europe generics market value forecast: $ billion, 2021-26
  • Table 21: Europe generics market volume forecast: %, 2021-26
  • Table 22: Europe size of population (million), 2017-21
  • Table 23: Europe gdp (constant 2005 prices, $ billion), 2017-21
  • Table 24: Europe gdp (current prices, $ billion), 2017-21
  • Table 25: Europe inflation, 2017-21
  • Table 26: Europe consumer price index (absolute), 2017-21
  • Table 27: Europe exchange rate, 2017-21
  • Table 28: France generics market value: $ million, 2016-21
  • Table 29: France generics market volume: %, 2016-21
  • Table 30: France generics market geography segmentation: $ million, 2021
  • Table 31: France generics market value forecast: $ million, 2021-26
  • Table 32: France generics market volume forecast: %, 2021-26
  • Table 33: France size of population (million), 2017-21
  • Table 34: France gdp (constant 2005 prices, $ billion), 2017-21
  • Table 35: France gdp (current prices, $ billion), 2017-21
  • Table 36: France inflation, 2017-21
  • Table 37: France consumer price index (absolute), 2017-21
  • Table 38: France exchange rate, 2017-21
  • Table 39: Germany generics market value: $ billion, 2016-21
  • Table 40: Germany generics market volume: %, 2016-21
  • Table 41: Germany generics market geography segmentation: $ billion, 2021
  • Table 42: Germany generics market value forecast: $ billion, 2021-26
  • Table 43: Germany generics market volume forecast: %, 2021-26
  • Table 44: Germany size of population (million), 2017-21
  • Table 45: Germany gdp (constant 2005 prices, $ billion), 2017-21
  • Table 46: Germany gdp (current prices, $ billion), 2017-21
  • Table 47: Germany inflation, 2017-21
  • Table 48: Germany consumer price index (absolute), 2017-21
  • Table 49: Germany exchange rate, 2017-21
  • Table 50: Australia generics market value: $ million, 2016-21
  • Table 51: Australia generics market volume: %, 2016-21
  • Table 52: Australia generics market geography segmentation: $ million, 2021
  • Table 53: Australia generics market value forecast: $ million, 2021-26
  • Table 54: Australia generics market volume forecast: %, 2021-26
  • Table 55: Australia size of population (million), 2017-21
  • Table 56: Australia gdp (constant 2005 prices, $ billion), 2017-21
  • Table 57: Australia gdp (current prices, $ billion), 2017-21
  • Table 58: Australia inflation, 2017-21
  • Table 59: Australia consumer price index (absolute), 2017-21
  • Table 60: Australia exchange rate, 2017-21
  • Table 61: Brazil generics market value: $ million, 2016-21
  • Table 62: Brazil generics market volume: %, 2016-21
  • Table 63: Brazil generics market geography segmentation: $ million, 2021
  • Table 64: Brazil generics market value forecast: $ million, 2021-26
  • Table 65: Brazil generics market volume forecast: %, 2021-26
  • Table 66: Brazil size of population (million), 2017-21
  • Table 67: Brazil gdp (constant 2005 prices, $ billion), 2017-21
  • Table 68: Brazil gdp (current prices, $ billion), 2017-21
  • Table 69: Brazil inflation, 2017-21
  • Table 70: Brazil consumer price index (absolute), 2017-21
  • Table 71: Brazil exchange rate, 2017-21
  • Table 72: Canada generics market value: $ million, 2016-21
  • Table 73: Canada generics market volume: %, 2016-21
  • Table 74: Canada generics market geography segmentation: $ million, 2021
  • Table 75: Canada generics market value forecast: $ million, 2021-26
  • Table 76: Canada generics market volume forecast: %, 2021-26
  • Table 77: Canada size of population (million), 2017-21
  • Table 78: Canada gdp (constant 2005 prices, $ billion), 2017-21
  • Table 79: Canada gdp (current prices, $ billion), 2017-21
  • Table 80: Canada inflation, 2017-21

List of Figures

  • Figure 1: Global generics market value: $ billion, 2016-21
  • Figure 2: Global generics market volume: %, 2016-21
  • Figure 3: Global generics market geography segmentation: % share, by value, 2021
  • Figure 4: Global generics market value forecast: $ billion, 2021-26
  • Figure 5: Global generics market volume forecast: %, 2021-26
  • Figure 6: Forces driving competition in the global generics market, 2021
  • Figure 7: Drivers of buyer power in the global generics market, 2021
  • Figure 8: Drivers of supplier power in the global generics market, 2021
  • Figure 9: Factors influencing the likelihood of new entrants in the global generics market, 2021
  • Figure 10: Factors influencing the threat of substitutes in the global generics market, 2021
  • Figure 11: Drivers of degree of rivalry in the global generics market, 2021
  • Figure 12: Asia-Pacific generics market value: $ billion, 2016-21
  • Figure 13: Asia-Pacific generics market volume: %, 2016-21
  • Figure 14: Asia-Pacific generics market geography segmentation: % share, by value, 2021
  • Figure 15: Asia-Pacific generics market value forecast: $ billion, 2021-26
  • Figure 16: Asia-Pacific generics market volume forecast: %, 2021-26
  • Figure 17: Forces driving competition in the generics market in Asia-Pacific, 2021
  • Figure 18: Drivers of buyer power in the generics market in Asia-Pacific, 2021
  • Figure 19: Drivers of supplier power in the generics market in Asia-Pacific, 2021
  • Figure 20: Factors influencing the likelihood of new entrants in the generics market in Asia-Pacific, 2021
  • Figure 21: Factors influencing the threat of substitutes in the generics market in Asia-Pacific, 2021
  • Figure 22: Drivers of degree of rivalry in the generics market in Asia-Pacific, 2021
  • Figure 23: Europe generics market value: $ billion, 2016-21
  • Figure 24: Europe generics market volume: %, 2016-21
  • Figure 25: Europe generics market geography segmentation: % share, by value, 2021
  • Figure 26: Europe generics market value forecast: $ billion, 2021-26
  • Figure 27: Europe generics market volume forecast: %, 2021-26
  • Figure 28: Forces driving competition in the generics market in Europe, 2021
  • Figure 29: Drivers of buyer power in the generics market in Europe, 2021
  • Figure 30: Drivers of supplier power in the generics market in Europe, 2021
  • Figure 31: Factors influencing the likelihood of new entrants in the generics market in Europe, 2021
  • Figure 32: Factors influencing the threat of substitutes in the generics market in Europe, 2021
  • Figure 33: Drivers of degree of rivalry in the generics market in Europe, 2021
  • Figure 34: France generics market value: $ million, 2016-21
  • Figure 35: France generics market volume: %, 2016-21
  • Figure 36: France generics market geography segmentation: % share, by value, 2021
  • Figure 37: France generics market value forecast: $ million, 2021-26
  • Figure 38: France generics market volume forecast: %, 2021-26
  • Figure 39: Forces driving competition in the generics market in France, 2021
  • Figure 40: Drivers of buyer power in the generics market in France, 2021
  • Figure 41: Drivers of supplier power in the generics market in France, 2021
  • Figure 42: Factors influencing the likelihood of new entrants in the generics market in France, 2021
  • Figure 43: Factors influencing the threat of substitutes in the generics market in France, 2021
  • Figure 44: Drivers of degree of rivalry in the generics market in France, 2021
  • Figure 45: Germany generics market value: $ billion, 2016-21
  • Figure 46: Germany generics market volume: %, 2016-21
  • Figure 47: Germany generics market geography segmentation: % share, by value, 2021
  • Figure 48: Germany generics market value forecast: $ billion, 2021-26
  • Figure 49: Germany generics market volume forecast: %, 2021-26
  • Figure 50: Forces driving competition in the generics market in Germany, 2021
  • Figure 51: Drivers of buyer power in the generics market in Germany, 2021
  • Figure 52: Drivers of supplier power in the generics market in Germany, 2021
  • Figure 53: Factors influencing the likelihood of new entrants in the generics market in Germany, 2021
  • Figure 54: Factors influencing the threat of substitutes in the generics market in Germany, 2021
  • Figure 55: Drivers of degree of rivalry in the generics market in Germany, 2021
  • Figure 56: Australia generics market value: $ million, 2016-21
  • Figure 57: Australia generics market volume: %, 2016-21
  • Figure 58: Australia generics market geography segmentation: % share, by value, 2021
  • Figure 59: Australia generics market value forecast: $ million, 2021-26
  • Figure 60: Australia generics market volume forecast: %, 2021-26
  • Figure 61: Forces driving competition in the generics market in Australia, 2021
  • Figure 62: Drivers of buyer power in the generics market in Australia, 2021
  • Figure 63: Drivers of supplier power in the generics market in Australia, 2021
  • Figure 64: Factors influencing the likelihood of new entrants in the generics market in Australia, 2021
  • Figure 65: Factors influencing the threat of substitutes in the generics market in Australia, 2021
  • Figure 66: Drivers of degree of rivalry in the generics market in Australia, 2021
  • Figure 67: Brazil generics market value: $ million, 2016-21
  • Figure 68: Brazil generics market volume: %, 2016-21
  • Figure 69: Brazil generics market geography segmentation: % share, by value, 2021
  • Figure 70: Brazil generics market value forecast: $ million, 2021-26
  • Figure 71: Brazil generics market volume forecast: %, 2021-26
  • Figure 72: Forces driving competition in the generics market in Brazil, 2021
  • Figure 73: Drivers of buyer power in the generics market in Brazil, 2021
  • Figure 74: Drivers of supplier power in the generics market in Brazil, 2021
  • Figure 75: Factors influencing the likelihood of new entrants in the generics market in Brazil, 2021
  • Figure 76: Factors influencing the threat of substitutes in the generics market in Brazil, 2021
  • Figure 77: Drivers of degree of rivalry in the generics market in Brazil, 2021
  • Figure 78: Canada generics market value: $ million, 2016-21
  • Figure 79: Canada generics market volume: %, 2016-21
  • Figure 80: Canada generics market geography segmentation: % share, by value, 2021
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!